UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health — Irwin, Pennsylvania

UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health is a clinical research site located in Irwin, Pennsylvania, United States 15642.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health?

UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health conducted?

UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Neoplasms.

Is UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health accredited by Crixeo Health?

UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.